<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00300560</url>
  </required_header>
  <id_info>
    <org_study_id>SirirajCEU49-004</org_study_id>
    <nct_id>NCT00300560</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli</brief_title>
  <official_title>Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <brief_summary>
    <textblock>
      In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated
      to receive colistin or conventional antibiotic regimen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated
      to receive colistin or conventional antibiotic regimen.The primary outcome is clinical
      response and secondary outcomes are microbiological response and adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2006</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical response</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiological response</measure>
  </secondary_outcome>
  <enrollment>152</enrollment>
  <condition>Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colistin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 yr.

          -  Hospitalized to Siriraj Hospital

          -  Infections with ESBL-producing E.coli or K.pneumoniae

          -  Consent informed consent

        Exclusion Criteria:

          -  Pregnancy or lactating mother

          -  Colistin allergy

          -  Neurologic diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Visanu Thamlikitkul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Visanu Thamlikitkul, MD</last_name>
    <phone>662 419 7000</phone>
    <phone_ext>6626</phone_ext>
    <email>sivth@mahidol.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Infectious disease and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunee Thanakhumtorn, RN</last_name>
      <phone>662 4197000</phone>
      <phone_ext>6616</phone_ext>
      <email>srstn@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Visanu Thamlikitkul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pornpan Koomanachai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hutsaya Tantipong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sriripetcharat Mekviwattanawong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pasri Maharomn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pinyo Rattanaumpawan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2006</study_first_submitted>
  <study_first_submitted_qc>March 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2006</study_first_posted>
  <last_update_submitted>May 19, 2006</last_update_submitted>
  <last_update_submitted_qc>May 19, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2006</last_update_posted>
  <keyword>ESBL-producing E.coli Infections</keyword>
  <keyword>ESBL-producing Klebsiella pneumoniae Infections</keyword>
  <keyword>Colistin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colistin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

